ATX-201

Thuốc Gốc

Small Molecule

ATX-201 is one of a family of novel compounds that inhibits microtubule polymerization. It is developed by Kythera Biopharmaceuticals, Inc. for the treatment of actinic keratosis. The company announced the decision to discontinue its ATX-201 clinical program for actinic keratosis. The Company determined that the program was not meeting their expected primary and exploratory objectives.

Chỉ Định : Investigated for use/treatment in actinic keratosis.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05765

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading